CYTK
Cytokinetics, Incorporated
$51.32−0.33 (−0.64%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Apr 30, 2004 – Nov 18, 2026, Dividends reinvested
- Final balance
- $5,260
- CAGR
- −2.81%
- Max drawdown
- −97.06%
Trailing returns (%)
CYTK's average annual return was 16.55% over the last 10 years and 0.50% over the last 20 years, through Nov 18, 2026. $10,000 in CYTK on Nov 18, 2016 grew to $46,234 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −17.16%
- 3M
- −32.56%
- 6M
- −31.74%
- YTD
- −19.23%
- 1Y
- −22.43%
Per year
- 3Y
- +16.52%
- 5Y
- +4.73%
- 10Y
- +16.55%
- 15Y
- +15.38%
- 20Y
- +0.50%
- Since 2004
- −2.81%
Annual returns
2004 from Apr 30 · 2026 through Nov 18
CYTK returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −19.23% |
| 2025 | +35.08% |
| 2024 | −43.66% |
| 2023 | +82.21% |
| 2022 | +0.53% |
| 2021 | +119.35% |
| 2020 | +95.85% |
| 2019 | +67.88% |
| 2018 | −22.45% |
| 2017 | −32.92% |
Metrics
Since 2004| Volatility | 69.39% |
|---|---|
| Sharpe ratio | 0.31 |
| Sortino ratio | 0.47 |
| Calmar ratio | −0.03 |
| Longest drawdown | 19.7 years |
Worst drawdowns
Since 2004| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −97.1% | May 2004 | Oct 2014 | Jan 2024 | 19.7 years |
| −72.4% | Jan 2024 | May 2025 | Not yet | 2.9 years so far |
| −1.5% | May 2004 | May 2004 | May 2004 | 2 days |